BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2010
View Archived Issues
Pharmaxis acquires Topigen and issues 3.2 million shares
Read More
Dainippon Sumitomo Pharma offers quarterly update
Read More
Insight into the mechanistic and molecular basis of entecavir resistance in HBV
Read More
Lung Rx and ImmuneWorks sign development agreement for IW-001 in IPF and PGD
Read More
Synergistic antitumor effects of tumor-targeted superantigen combined with anti-CTLA-4
Read More
Merck & Co. discloses novel HIV integrase inhibitors
Read More
New PAI-1 inhibitors identified by Kowa
Read More
Novel neuroprotective agent Indip shows promise in stroke model
Read More
Vitae Pharmaceuticals identifies new renin inhibitors
Read More
MAP initiates PK study of Levadex in smokers and nonsmokers
Read More
TopoTarget discloses novel NMPRTase inhibitors
Read More
Tyrosine kinase inhibitors for cancer therapy disclosed by Merck KGaA
Read More
Embera and Exponential sign clinical development agreement for EMB-001C
Read More
U.K. MHRA approves Oncolytics' phase III trial of Reolysin in head and neck cancers
Read More
Quark granted orphan drug designation for QPI-1002 in DGF in kidney transplants
Read More
FDA approves REMS for erythropoiesis-stimulating agents
Read More
Prezista approved for pediatric use in Canada
Read More
Athersys completes enrollment in phase I trial of stem cell therapy MultiStem in AMI
Read More
ImmuneRegen and Fred Hutchinson Cancer Research Center to initiate homspera trials
Read More
PARI Pharma begins enrollment in phase IIb L-CsA trial in bronchiolitis obliterans
Read More
Alkermes reports phase I results of ALKS-37 in opioid-induced constipation
Read More
Novel selective and orally active inhibitors of PKB show potent antitumor effects in vivo
Read More
ERYtech and M.D. Anderson Cancer Center to develop biomarker assay for personalized treatment
Read More
Wyeth discloses the discovery of novel PARP-1 inhibitors
Read More